2,567
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Dexmedetomidine inhibits the NF-κB pathway and NLRP3 inflammasome to attenuate papain-induced osteoarthritis in rats

, , , , &
Pages 649-659 | Received 15 Apr 2019, Accepted 30 Jul 2019, Published online: 23 Sep 2019

References

  • Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, Taxman DJ, Guthrie EH, Pickles RJ, Ting JP. 2009. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity. 30(4):556–565.
  • Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA. 2009. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 183(2):787–791.
  • Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B. 2005. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis. 64(9):1263–1267.
  • Bhana N, Goa KL, McClellan KJ. 2000. Dexmedetomidine. Drugs. 59(2):263–268. discussion 269–70.
  • Bougault C, Gosset M, Houard X, Salvat C, Godmann L, Pap T, Jacques C, Berenbaum F. 2012. Stress-induced cartilage degradation does not depend on the NLRP3 inflammasome in human osteoarthritis and mouse models. Arthritis Rheum. 64(12):3972–3981.
  • Buckwalter JA, Mankin HJ. 1998. Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect. 47:487–504.
  • Chen J, Crawford R, Xiao Y. 2013. Vertical inhibition of the PI3K/Akt/mTOR pathway for the treatment of osteoarthritis. J Cell Biochem. 114(2):245–249.
  • Cheng OT, Souzdalnitski D, Vrooman B, Cheng J. 2012. Evidence-based knee injections for the management of arthritis. Pain Med. 13(6):740–753.
  • Grall F, Gu X, Tan L, Cho JY, Inan MS, Pettit AR, Thamrongsak U, Choy BK, Manning C, Akbarali Y, et al. 2003. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1. Arthritis Rheum. 48(5):1249–1260.
  • Guler-Yuksel M, Allaart CF, Watt I, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van Schaardenburg D, van Krugten MV, Dijkmans BA, Huizinga TW, Lems WF, et al. 2010. Treatment with TNF-α inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis. Osteoarthr Cartil. 18(10):1256–1262.
  • Haywood L, McWilliams DF, Pearson CI, Gill SE, Ganesan A, Wilson D, Walsh DA. 2003. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum. 48(8):2173–2177.
  • Ji Q, Xu X, Zhang Q, Kang L, Xu Y, Zhang K, Li L, Liang Y, Hong T, Ye Q, et al. 2016. The IL-1β/AP-1/miR-30a/ADAMTS-5 axis regulates cartilage matrix degradation in human osteoarthritis. J Mol Med. 94(7):771–785.
  • Kalbhen DA. 1987. Chemical model of osteoarthritis – a pharmacological evaluation. J Rheumatol. 14:130–131.
  • Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, et al. 2008. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 58(1):26–35.
  • Li H, Ji F, Zhou Y, Zhou S, Ji D, Xu H. 2016. IFN-γ is involved in the analgesic effect of dexmedetomidine in a rat model of monoarthritis. Prog Modern Biomed. 16:5847–5850.
  • Li H, Zhang X, Chen M, Chen J, Gao T, Yao S. 2018a. Dexmedetomidine inhibits inflammation in microglia cells under stimulation of LPS and ATP by C-FOS/NLRP3/CASPASE-1 cascades. Excli J. 17:302–311.
  • Li Y, Pan Y, Gao L, Lu G, Zhang J, Xie X, Tong Z, Li B, Li G, Li W. 2018b. Dexmedetomidine attenuates pancreatic injury and inflammatory response in mice with pancreatitis by possible reduction of NLRP3 activation and up-regulation of NET expression. Biochem Biophys Res Commun. 495(4):2439–2447.
  • Lin H, Hay E, Latourte A, Funck-Brentano T, Bouaziz W, Ea HK, Khatib AM, Richette P, Cohen-Solal M. 2018. Proprotein convertase furin inhibits matrix metalloproteinase 13 in a TGFβ-dependent manner and limits osteoarthritis in mice. Sci Rep. 8(1):10488.
  • Lin P, Ma Y, Cheng H, Shao X, Zheng W, Zheng X, Li X, Ye H. 2016. Mechanism of Duhuo Jisheng decoction regulating inflammation and inhibiting cartilage degeneration of osteoarthritis. ArthritisRheum. 5:51–54.
  • Lisignoli G, Cristino S, Toneguzzi S, Grassi F, Piacentini A, Cavallo C, Facchini A, Mariani E. 2004. IL1beta and TNFalpha differently modulate CXCL13 chemokine in stromal cells and osteoblasts isolated from osteoarthritis patients: evidence of changes associated to cell maturation. Exp Gerontol. 39(4):659–665.
  • Lv M, Zeng H, He Y, Zhang J, Tan G. 2018. Dexmedetomidine promotes liver regeneration in mice after 70% partial hepatectomy by suppressing NLRP3 inflammasome not TLR4/NFkappaB. Int Immunopharmacol. 54:46–51.
  • Ma W, Liang Y. 2017. An experimental research on the analgesis effect and underlying mechanism of BTX-A for rat knee osteoarthritis. Chin J Rehabil Med. 32:649–653.
  • Margerie D, Flechtenmacher J, Büttner F, Karbowski A, Puhl W, Schleyerbach R, Bartnik E. 1997. Complexity of IL-1β induced gene expression pattern in human articular chondrocytes. Osteoarthritis Cartilage. 5(2):129–138.
  • McAllister MJ, Chemaly M, Eakin A, Gibson D, McGilligan V. 2018. NLRP3 as a potentially novel biomarker for the management of osteoarthritis. Osteoarthr Cartil. 26(5):612–619.
  • McCarthy GM, Cheung HS. 2009. Point: hydroxyapatite crystal deposition is intimately involved in the pathogenesis and progression of human osteoarthritis. Curr Rheumatol Rep. 11(2):141–147.
  • Memiş D, Hekimoğlu S, Vatan I, Yandim T, Yüksel M, Süt N. 2007. Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients. Br J Anaesth. 98(4):550–552.
  • Mridha AR, Wree A, Robertson AAB, Yeh MM, Johnson CD, Van Rooyen DM, Haczeyni F, Teoh NC-H, Savard C, Ioannou GN, et al. 2017. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol. 66(5):1037–1046.
  • Murat N, Karadam B, Ozkal S, Karatosun V, Gidener S. 2007. Quantification of papain-induced rat osteoarthritis in relation to time with the Mankin score. Acta Orthop Traumatol Turc. 41(3):233–237.
  • Nixon AJ, Grol MW, Lang HM, Ruan MZC, Stone A, Begum L, Chen Y, Dawson B, Gannon F, Plutizki S, et al. 2018. Disease‐modifying osteoarthritis treatment with interleukin‐1 receptor antagonist gene therapy in small and large animal models. Arthritis Rheumatol. 70(11):1757–1768.
  • Qiao H, Sanders RD, Ma D, Wu X, Maze M. 2009. Sedation improves early outcome in severely septic Sprague Dawley rats. Crit Care. 13(4):R136.
  • Qiao Y, Wang P, Qi J, Zhang L, Gao C. 2012. TLR-induced NF-κB activation regulates NLRP3 expression in murine macrophages. FEBS Lett. 586(7):1022–1026.
  • Ramonda R, Oliviero F, Scanu A, Campana C, Lorenzin M, Modesti V, Frallonardo P, Punzi L. 2014. FRI0319 Levels of IL-1 and MMP-3 are increased in the synovial fluid from knee osteoarthritis (OA) in patients with concomitant erosive hand OA. Ann Rheum Dis. 71:421.3–422.
  • Roman-Blas JA, Jimenez SA. 2006. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthr Cartil. 14(9):839–848.
  • Sun Y, Liu W, Zhang H, Li H, Liu J, Zhang F, Jiang T, Jiang S. 2017. Curcumin prevents osteoarthritis by inhibiting the activation of inflammasome NLRP3. J Interferon Cytokine Res. 37(10):449–455.
  • Taniguchi T, Kurita A, Kobayashi K, Yamamoto K, Inaba H. 2008. Dose- and time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats. J Anesth. 22(3):221–228.
  • Toegel S, Wu SQ, Otero M, Goldring MB, Leelapornpisid P, Chiari C, Kolb A, Unger FM, Windhager R, Viernstein H. 2012. Caesalpinia sappan extract inhibits IL1β-mediated overexpression of matrix metalloproteinases in human chondrocytes. Genes Nutr. 7(2):307–318.
  • Tomita T, Takeuchi E, Tomita N, Morishita R, Kaneko M, Yamamoto K, Nakase T, Seki H, Kato K, Kaneda Y, et al.. 1999. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy. Arthritis Rheum. 42(12):2532–2542.
  • Towle CA, Hung HH, Bonassar LJ, Treadwell BV, Mangham DC. 1997. Detection of interleukin-1 in the cartilage of patients with osteoarthritis: a possible autocrine/paracrine role in pathogenesis. Osteoarthritis Cartilage. 5(5):293–300.
  • Vincenti MP, Brinckerhoff CE. 2001. Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1beta. Arthritis Res. 3(6):381–388.
  • Wang C, Zeng L, Zhang T, Liu J, Wang W. 2016. Tenuigenin prevents IL-1β-induced inflammation in human osteoarthritis chondrocytes by suppressing PI3K/AKT/NF-κB signaling pathway. Inflammation. 39(2):807–812.
  • Xia L. 2010. Histopathology of knee joint synovial tissue and expression of cytokines IL-1β and TNF-α in rabbits with osteoarthritis. Hefei (China): Anhui Medical University.
  • Xu B, Zhang WS, Yang JL, Lu N, Deng XM, Xu H, Zhang YQ. 2010. Evidence for suppression of spinal glial activation by dexmedetomidine in a rat model of monoarthritis. Clin Exp Pharmacol Physiol. 37(10):e158–66.
  • Yao H, Chi X, Jin Y, Wang Y, Huang P, Wu S, Xia Z, Cai J. 2015. Dexmedetomidine inhibits TLR4/NF-κB activation and reduces acute kidney injury after orthotopic autologous liver transplantation in rats. Sci Rep. 5:16849.
  • Yin D, Zhou S, Xu X, Gao W, Li F, Ma Y, Sun D, Wu Y, Guo Q, Liu H, et al. 2018. Dexmedetomidine attenuated early brain injury in rats with subarachnoid haemorrhage by suppressing the inflammatory response: the TLR4/NF-κB pathway and the NLRP3 inflammasome may be involved in the mechanism. Brain Res. 1698:1–10.
  • Zhang A, Wang S, Zhang J, Wu H. 2016. Genipin alleviates LPS-induced acute lung injury by inhibiting NF-κB and NLRP3 signaling pathways. Int Immunopharmacol. 38:115–119.
  • Zhang C, Boini KM, Xia M, Abais JM, Li X, Liu Q, Li PL. 2012. Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia. Hypertension. 60(1):154–162.
  • Zhang J, Wang Z, Wang Y, Zhou G, Li H. 2015. The effect of dexmedetomidine on inflammatory response of septic rats. BMC Anesthesiol. 15:68.
  • Zhang WS, Xu H, Xu B, Sun S, Deng XM, Zhang YQ. 2009. Antihyperalgesic effect of systemic dexmedetomidine and gabapentin in a rat model of monoarthritis. Brain Res. 1264:57–66.
  • Zhong HM, Ding QH, Chen WP, Luo RB. 2013. Vorinostat, a HDAC inhibitor, showed anti-osteoarthritic activities through inhibition of iNOS and MMP expression, p38 and ERK phosphorylation and blocking NF-kappaB nuclear translocation. Int Immunopharmacol. 17(2):329–335.
  • Zhou PH, Liu SQ, Peng H. 2008. The effect of hyaluronic acid on IL-1beta-induced chondrocyte apoptosis in a rat model of osteoarthritis. J Orthop Res. 26(12):1643–1648.
  • Zhou R, Yazdi AS, Menu P, Tschopp J. 2011. A role for mitochondria in NLRP3 inflammasome activation. Nature. 469(7329):221–225.
  • Zhu T, Zhang L, Ling S, Duan J, Qian F, Li Y, Xu JW. 2014. Scropolioside B inhibits IL-1β and cytokines expression through NF-κB and inflammasome NLRP3 pathways. Mediators Inflamm. 2014:819053.